Alkaptonuria - Many questions answered, further challenges beckon.

Davison, A S; Hughes, A T; Milan, A M; Sireau, N; Gallagher, J A; Ranganath, L R

Davison, A S; Hughes, A T; Milan, A M; Sireau, N; Gallagher, J A; Ranganath, L R.

Afiliação

Davison AS; Department of Clinical Biochemistry and Metabolic Medicine, Liverpool Clinical Laboratories, Royal Liverpool University Hospitals Trust, Liverpool, UK.
Hughes AT; Musculoskeletal Biology I, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool Health Partners, Liverpool, UK.
Milan AM; Department of Clinical Biochemistry and Metabolic Medicine, Liverpool Clinical Laboratories, Royal Liverpool University Hospitals Trust, Liverpool, UK.
Sireau N; Musculoskeletal Biology I, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool Health Partners, Liverpool, UK.
Gallagher JA; Department of Clinical Biochemistry and Metabolic Medicine, Liverpool Clinical Laboratories, Royal Liverpool University Hospitals Trust, Liverpool, UK.
Ranganath LR; Musculoskeletal Biology I, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool Health Partners, Liverpool, UK.

Ann Clin Biochem ; 57(2): 106-120, 2020 03.

Article em En | MEDLINE | ID: mdl-31529982

Assuntos

Alcaptonúria; Cicloexanonas/uso terapêutico; Inibidores Enzimáticos/uso terapêutico; Nitrobenzoatos/uso terapêutico; Alcaptonúria/tratamento farmacológico; Alcaptonúria/genética; Alcaptonúria/metabolismo; Animais; Modelos Animais de Doenças; Ácido Homogentísico/metabolismo; Humanos; Camundongos; Tirosina/metabolismo

Palavras-chave

Alkaptonuria; metabolism; nitisinone; tyrosine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cicloexanonas / Alcaptonúria / Inibidores Enzimáticos / Nitrobenzoatos Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google